US 11549110
Modified short interfering nucleic acid (siNA) molecules and uses thereof
granted A61KA61K31/713A61K45/06
Quick answer
US patent 11549110 (Modified short interfering nucleic acid (siNA) molecules and uses thereof) held by Aligos Therapeutics, Inc. expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/713, A61K45/06, A61P, A61P31/20